(156), as well as the retrospective analysis of data collected from a world-wide registry in which sixty patients with alveolar soft part sarcomas and treated with PD1/PD-L1 in Europe, Australia and USA (157). This evidence concerns the gene CD274 and alveolar soft part sarcoma.